Kurisu Tada Selected Research

Kurisu Tada Research Topics

4	Infections 05/2023 - 01/2020
4	Arthritis (Polyarthritis) 10/2022 - 01/2021
4	Rheumatoid Arthritis 01/2021 - 02/2012
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2023 - 04/2020
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020 - 01/2017
2	Tuberculosis (Tuberculoses) 05/2023 - 08/2021
2	Ankylosing Spondylitis 03/2023 - 06/2018
2	Axial Spondyloarthritis 11/2022 - 01/2019
2	Inflammation (Inflammations) 11/2022 - 06/2018
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022 - 11/2019
2	Microscopic Polyangiitis 06/2022 - 04/2020
2	Hemorrhage 06/2022 - 04/2020
2	Tonsillitis 08/2021 - 01/2021
2	Non-Radiographic Axial Spondyloarthritis 03/2021 - 01/2021
2	Sacroiliitis 01/2021 - 11/2019
2	Lung Diseases (Lung Disease) 01/2021 - 07/2019
2	Rheumatic Diseases (Rheumatism) 07/2019 - 02/2019
2	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 07/2019 - 02/2019
1	Polyarteritis Nodosa (Periarteritis Nodosa) 06/2023
1	COVID-19 06/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2021
1	Lupus Nephritis 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Viral Meningitis 01/2021
1	Experimental Arthritis 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Giant Cell Arteritis (Horton Disease) 11/2020
1	Central Nervous System Vasculitis 11/2020
1	Anaphylaxis (Anaphylactic Shock) 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Fever (Fevers) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Psoriatic Arthritis 11/2019
1	Myositis (Idiopathic Inflammatory Myopathies) 03/2018
1	Dermatitis 01/2017
1	Necrosis 07/2004

5	HLA-B27 Antigen (HLA B27 Antigen)IBA 03/2023 - 01/2019
4	Antirheumatic Agents (DMARD)IBA 01/2021 - 02/2012
3	C-Reactive ProteinIBA 11/2022 - 01/2021
3	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 03/2018
2	GlucocorticoidsIBA 04/2020 - 07/2019
2	AntibodiesIBA 01/2020 - 03/2018
1	COVID-19 VaccinesIBA 06/2023
1	VaccinesIBA 06/2023
1	belimumabIBA 05/2023
1	Adalimumab (Humira)FDA Link 11/2022
1	ixekizumabIBA 11/2022
1	Tumor Necrosis Factor InhibitorsIBA 11/2022
1	Interleukin-17 (Interleukin 17)IBA 03/2021
1	palbociclibIBA 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	Cyclin-Dependent Kinase 4IBA 01/2021
1	AcidsIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Proteins (Proteins, Gene)FDA Link 11/2020
1	HLA-B46 antigenIBA 11/2019
1	Thymidine Monophosphate (TMP)IBA 02/2019
1	Trimethoprim (Proloprim)FDA LinkGeneric 02/2019
1	Sulfamethoxazole FDA LinkGeneric 02/2019
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 06/2018
1	SteroidsIBA 06/2018
1	Rheumatoid FactorIBA 03/2018
1	Ligases (Synthetase)IBA 03/2018
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 03/2018
1	cyclic citrullinated peptideIBA 03/2018
1	RNA (Ribonucleic Acid)IBA 03/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2017
1	Ferritins (Ferritin)IBA 01/2017
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2017
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2004

8	Therapeutics 05/2023 - 02/2012
3	Plasma Exchange 06/2022 - 01/2020
1	Biological Therapy 05/2023
1	Intravesical Administration 08/2021
1	Tonsillectomy 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Catheters 01/2020